If you don’t have a precise grasp on the gross to net (GTN) of your products, you may be over- or understating their profitability. And that can result in regulatory complications, dissatisfied stakeholders, and negative impacts to your brand’s reputation. Before you make another go-to-market financial decision about your products, you need to take a closer look at this strategically critical metric.

Watch speakers from Model N as they discuss how you can generate net-price calculations by taking a streamlined approach to managing this complex price waterfall. Our presenters will share ways to overcome the challenges with data availability, accuracy, and ecosystem complexity that often prevent pharmaceutical and biotech manufacturers from optimizing their GTN – and, ultimately, protecting the profitability of their products.

Watch the webinar to learn:

• The importance of having a single source of truth for all GTN decisions
• How to ensure your data is clean, consolidated, and consistent
• How to create an interdisciplinary functional team that applies processes and technology to approach GTN more strategically

Featured Speaker

Erik Maddox

Sr. Product Manager

Model N